Figure 1
The profile of platelet interactions with VWF is markedly different in patients with ACS. Dynamic platelet interaction with VWF in patients with ACS and stable CAD was normalised against healthy controls (bars represent normalised 95% confidence intervals). Platelets from patients with ACS have a higher rate of interaction with the surface compared to healthy controls and stable patients on aspirin alone.

The profile of platelet interactions with VWF is markedly different in patients with ACS. Dynamic platelet interaction with VWF in patients with ACS and stable CAD was normalised against healthy controls (bars represent normalised 95% confidence intervals). Platelets from patients with ACS have a higher rate of interaction with the surface compared to healthy controls and stable patients on aspirin alone.

Close Modal

or Create an Account

Close Modal
Close Modal